YanXingMD

Physician

Dr. Xing is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Medical Oncology and Therapeutics Research
1500 East Duarte Road
Duarte, CA 91010
Phone+1 626-256-4673

Fax+1 626-218-8233

Methodist Hospital (Houston)Fellowship, Hematology and Medical Oncology, 2015 - 2017
Mount Auburn HospitalResidency, Internal Medicine, 2012 - 2015
Sun Yat-Sen University of Medical ScienceClass of 1994

PubMed

The Impact of Medicaid Expansion on Stage at Diagnosis of Melanoma Patients: A Retrospective Study.
Ramya Muddasani, Helena T Wu, Shwe Win, Arya Amini, Badri Modi
Cancers. 2024-12-28
1 citations
Advancements and Challenges in Personalized Therapy for-Mutant Melanoma: A Comprehensive Review.
Abdulaziz Shebrain, Omer A Idris, Ali Jawad, Tiantian Zhang, Yan Xing
Journal of Clinical Medicine. 2024-09-12
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors.
Maxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, Drew Rasco, Yan Xing
Investigational New Drugs. 2024-06-01

Defence to Perform Final AccuTOXTM Preclinical Study Before Phase I Cancer TrialMarch 29th, 2023
Defence to Complete a Final Pre-Clinical Study Prior to Ind Filings for the Accutoxtm Phase I Cancer Trial at the City of Hope National Medical Center and Beckman Research InstituteMarch 28th, 2023